These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28604112)

  • 21. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
    Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
    Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients.
    Ampudia-Blasco FJ; Galán M; Brod M
    Endocrinol Nutr; 2014 Oct; 61(8):426-33. PubMed ID: 24853553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
    Batais MA; Schantter P
    Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions of diabetes control among physicians and people with type 2 diabetes uncontrolled on basal insulin in Sweden, Switzerland, and the United Kingdom.
    Brod M; Pfeiffer KM; Barnett AH; Berntorp K; Vilsbøll T; Weissenberger B
    Curr Med Res Opin; 2016 Jun; 32(6):981-9. PubMed ID: 26849483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
    Davies M; Evans R; Storms F; Gomis R; Khunti K
    Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment persistence in the use of basal insulins in Poland and Germany
.
    Rathmann W; Czech M; Franek E; Kostev K
    Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.
    Farr AM; Sheehan JJ; Curkendall SM; Smith DM; Johnston SS; Kalsekar I
    Adv Ther; 2014 Dec; 31(12):1287-305. PubMed ID: 25504156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with persistence and resumption of insulin pen use for patients with type 2 diabetes.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2011 Jan; 13(1):43-8. PubMed ID: 21175270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin therapy for diabetes mellitus: treatment regimens and associated costs.
    Charbonnel B; Penfornis A; Varroud-Vial M; Kusnik-Joinville O; Detournay B
    Diabetes Metab; 2012 Apr; 38(2):156-63. PubMed ID: 22172400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
    Ruiz de Adana MS; Colomo N; Maldonado-Araque C; Fontalba MI; Linares F; García-Torres F; Fernández R; Bautista C; Olveira G; de la Cruz JL; Rojo-Martínez G; Valdés S
    Diabetes Res Clin Pract; 2015 Nov; 110(2):158-65. PubMed ID: 26474657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
    Leiter LA; Boras D; Woo VC
    Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians.
    Brod M; Rana A; Barnett AH
    Curr Med Res Opin; 2012 Dec; 28(12):1947-58. PubMed ID: 23150950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing Patient Acceptance and Adherence Toward Insulin.
    Riddle M; Peters A; Funnell M
    Postgrad Med; 2016 Oct; 128 Suppl 1():11-20. PubMed ID: 27109558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonality of Insulin Use in German Outpatients With Diabetes: A Retrospective Analysis.
    Kostev K; Gläser S; Jacob L
    J Diabetes Sci Technol; 2017 Sep; 11(5):996-1000. PubMed ID: 28420259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus.
    Peyrot M; Rubin RR
    Curr Med Res Opin; 2008 Aug; 24(8):2413-22. PubMed ID: 18627641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing barriers to medication adherence in underserved patients with diabetes in Texas.
    Bailey GR; Barner JC; Weems JK; Leckbee G; Solis R; Montemayor D; Pope ND
    Diabetes Educ; 2012; 38(2):271-9. PubMed ID: 22316643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of exenatide, pen insulin, and vial insulin on patient outcomes: a retrospective database analysis of persistence and first-year costs in a commercially insured population.
    Rashid N; McCombs JS; Schwartz E
    Clin Ther; 2012 May; 34(5):1145-58. PubMed ID: 22464691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.